Pituitary adenylate cyclase-activating polypeptide protects astroglial cells against oxidative stress-induced apoptosis

Journal of Neurochemistry

Volumn 117, Issue 3, 2011, Pages 403-411

  Masmoudi Kouki, Olfa ^a   Douiri, Salma ^a   Hamdi, Yosra ^a   Kaddour, Hadhémi ^a   Bahdoudi, Saima ^a   Vaudry, David ^b   Basille, Magali ^b   Leprince, Jérôme ^b   Fournier, Alain ^a,c   Vaudry, Hubert ^b   Tonon, Marie Christine ^b   Amri, Mohamed ^a  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b UNIVERSITÉ DE ROUEN   (France)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

apoptosis; astrocytes; glutathione; oxidative stress; PACAP

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CASPASE 3; CHELERYTHRINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTATHIONE; HYDROGEN PEROXIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; RECEPTOR BLOCKING AGENT; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVATION; INHIBITION KINETICS; MACROGLIA; MITOCHONDRION; NEUROPROTECTION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; ASTROCYTES; CASPASE 3; CELLS, CULTURED; CEREBELLUM; CEREBRAL CORTEX; CULTURE MEDIA, CONDITIONED; DRUG INTERACTIONS; GLUTATHIONE; HYDROGEN PEROXIDE; MITOCHONDRIA; NEURONS; OXIDATIVE STRESS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

RATTUS;

EID: 79954424855     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07185.x     Document Type: Article

References (47)

1. Allais A., Burel D., and, Roy V., et al. (2010) Balanced effect of PACAP and FasL on granule cell death during cerebellar development: a morphological, functional and behavioural characterization. J. Neurochem. 113, 329-340.
2. Bolanos J. P., Heales S. J., Peuchen S., Barker J. E., Land J. M., and, Clark J. B., (1996) Nitric oxide-mediated mitochondrial damage: a potential neuroprotective role for glutathione. Free Radic. Biol. Med. 21, 995-1001. (Pubitemid 26365953)
3. Brenneman D. E., Hauser J. M., Spong C., and, Phillips T. M., (2002) Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity. Neuropeptides 36, 271-280. (Pubitemid 35192189)
4. Brown D. R., and, Mohn C. M., (1999) Astrocytic glutamate uptake and prion protein expression. Glia 25, 282-292. (Pubitemid 29060224)
5. Castel H., Diallo M., Chatenet D., et al. (2006) Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes. J. Neurochem. 99, 582-595. (Pubitemid 44477213)
6. Deguil J., Chavant F., Lafay-Chebassier C., Perault-Pochat M. C., Fauconneau B., and, Pain S., (2010) Neuroprotective effect of PACAP on translational control alteration and cognitive decline in MPTP parkinsonian mice. Neurotox. Res. 17, 142-155.
7. Dejda A., Sokolowska P., and, Nowak J. Z., (2005) Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. Pharmacol. Rep. 57, 307-320. (Pubitemid 41030690)
8. Dong Y., Liu H. D., Zhao R., Yang C. Z., Chen X. Q., Wang X. H., Lau L. T., Chen J., and, Yu A. C., (2009) Ischemia activates JNK/c-Jun/AP-1 pathway to up-regulate 14-3-3γ in astrocyte. J. Neurochem. 109, 182-188.
9. Dringen R., Gutterer J. M., and, Hirrlinger J., (2000) Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur. J. Biochem. 267, 4912-4916. (Pubitemid 30641287)
10. Emerit J., Edeas M., and, Bricaire F., (2004) Neurodegenerative diseases and oxidative stress. Biomed. Pharmacother. 58, 39-46. (Pubitemid 38117047)
11. Falluel-Morel A., Aubert N., Vaudry D., Basille M., Fontaine M., Fournier A., Vaudry H., and, Gonzalez B. J., (2004) Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J. Neurochem. 91, 1231-1243. (Pubitemid 39587461)
12. Feeney C. J., Frantseva M. V., Carlen P. L., Pennefather P. S., Shulyakova N., Shniffer C., and, Mills L. R., (2008) Vulnerability of glial cells to hydrogen peroxide in cultured hippocampal slices. Brain Res. 1198, 1-15.
13. Ferrero-Gutierrez A., Perez-Gomez A., Novelli A., and, Fernandez-Sanchez M. T., (2008) Inhibition of protein phosphatases impairs the ability of astrocytes to detoxify hydrogen peroxide. Free Radic. Biol. Med. 44, 1806-1816.
14. Fubini B., and, Hubbard A., (2003) Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic. Biol. Med. 34, 1507-1516. (Pubitemid 36638711)
15. Hashimoto H., Kunugi A., Arakawa N., et al. (2003) Possible involvement of a cyclic AMP-dependent mechanism in PACAP-induced proliferation and ERK activation in astrocytes. Biochem. Biophys. Res. Commun. 311, 337-343. (Pubitemid 37340082)
16. Huang T., Solano J., He D., Loutfi M., Dietrich W. D., and, Kuluz J. W., (2009) Traumatic injury activates MAP kinases in astrocytes: mechanisms of hypothermia and hyperthermia. J. Neurotrauma 26, 1535-1545.
17. Jaworski D. M., (2000) Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury. Cell Tissue Res. 300, 219-230. (Pubitemid 30333175)
18. Jolivel V., Basille M., Aubert N., et al. (2009) Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates. Neuroscience 160, 434-451.
19. Joo K. M., Chung Y. H., Kim M. K., Nam R. H., Lee B. L., Lee K. H., and, Cha C. I., (2004) Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J. Comp. Neurol. 476, 388-413. (Pubitemid 39025246)
20. Kaur P., Aschner M., and, Syversen T., (2007) Role of glutathione in determining the differential sensitivity between the cortical and cerebellar regions towards mercury-induced oxidative stress. Toxicology 230, 164-177. (Pubitemid 46109136)
21. 2-induced neural injury via enhancing glutamate uptake. Free Radic. Biol. Med. 45, 1705-1713.
22. Magistretti P. J., Cardinaux J. R., and, Martin J. L., (1998) VIP and PACAP in the CNS: regulators of glial energy metabolism and modulators of glutamatergic signaling. Ann. N Y Acad. Sci. 865, 213-225. (Pubitemid 29047830)
23. Masmoudi O., Gandolfo P., Leprince J., Vaudry D., Fournier A., Patte-Mensah C., Vaudry H., and, Tonon M. C., (2003) Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism. FASEB J. 17, 17-27. (Pubitemid 36119831)
24. Masmoudi-Kouki O., Gandolfo P., Castel H., Leprince J., Fournier A., Dejda A., Vaudry H., and, Tonon M. C., (2007) Role of PACAP and VIP in astroglial functions. Peptides 28, 1753-1760. (Pubitemid 47361428)
25. May V., Lutz E., MacKenzie C., Schutz K. C., Dozark K., and, Braas K. M., (2010) Pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through phosphatidylinositol 3-kinase γ and vesicle endocytosis for neuronal survival. J. Biol. Chem. 285, 9749-9761.
26. Miyata A., Arimura A., Dahl R. R., Minamino N., Uehara A., Jiang L., Culler M. D., and, Coy D. H., (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164, 567-574. (Pubitemid 19269770)
27. Moroo I., Tatsuno I., Uchida D., Tanaka T., Saito J., Saito Y., and, Hirai A., (1998) Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates mitogen-activated protein kinase (MAPK) in cultured rat astrocytes. Brain Res. 795, 191-196. (Pubitemid 28337830)
28. Nakamachi T., Nakamura K., Oshida K., et al. (2011) Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates proliferation of reactive astrocytes in vitro. J. Mol. Neurosci. 43, 16-21.
29. Nishimoto M., Furuta A., Aoki S., Kudo Y., Miyakawa H., and, Wada K., (2007) PACAP/PAC1 autocrine system promotes proliferation and astrogenesis in neural progenitor cells. Glia 55, 317-327. (Pubitemid 46225964)
30. Ohtaki H., Nakamachi T., Dohi K., et al. (2006) Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc. Natl Acad. Sci. USA 103, 7488-7493. (Pubitemid 43727860)
31. Perez V., Bouschet T., Fernandez C., Bockaert J., and, Journot L., (2005) Dynamic reorganization of the astrocyte actin cytoskeleton elicited by cAMP and PACAP: a role for phosphatidylInositol 3-kinase inhibition. Eur. J. Neurosci. 21, 26-32. (Pubitemid 40193872)
32. Rana S., and, Dringen R., (2007) Gap junction hemichannel-mediated release of glutathione from cultured rat astrocytes. Neurosci. Lett. 415, 45-48. (Pubitemid 46356717)
33. Reynolds A., Laurie C., Mosley R. L., and, Gendelman H. E., (2007) Oxidative stress and the pathogenesis of neurodegenerative disorders. Int. Rev. Neurobiol. 82, 297-325.
34. Sandhu J. K., Gardaneh M., Iwasiow R., Lanthier P., Gangaraju S., Ribecco-Lutkiewicz M., Tremblay R., Kiuchi K., and, Sikorska M., (2009) Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity. Neurobiol. Dis. 33, 405-414.
35. Shieh P. C., Tsao C. W., Li J. S., Wu H. T., Wen Y. J., Kou D. H., and, Cheng J. T., (2008) Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against β-amyloid-induced inhibition of rat brain astrocytes. Neurosci. Lett. 434, 1-5.
36. Shioda S., Ohtaki H., Suzuki R., Nakamachi T., Takenoya F., Dohi K., and, Nakajo S., (2004) Prevention of delayed neuronal cell death by PACAP and its molecular mechanism. Nippon Yakurigaku Zasshi 123, 243-252. (Pubitemid 38478381)
37. Shioda S., Ohtaki H., Nakamachi T., et al. (2006) Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment. Ann. N Y Acad. Sci. 1070, 550-560. (Pubitemid 44126702)
38. Somogyvari-Vigh A., and, Reglodi D., (2004) Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr. Pharm. Des. 10, 2861-2889. (Pubitemid 39172068)
39. Stumm R., Kolodziej A., Prinz V., Endres M., Wu D. F., and, Hollt V., (2007) Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage. J. Neurochem. 103, 1666-1681. (Pubitemid 47631830)
40. Suzuki R., Arata S., Nakajo S., Ikenaka K., Kikuyama S., and, Shioda S., (2003) Expression of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC1-R) in reactive astrocytes. Mol. Brain Res. 115, 10-20. (Pubitemid 36725031)
41. Takuma K., Fujita T., Kimura Y., et al. (2000) T-588 inhibits astrocyte apoptosis via mitogen-activated protein kinase signal pathway. Eur. J. Pharmacol. 399, 1-8. (Pubitemid 30392378)
42. Takuma K., Baba A., and, Matsuda T., (2004) Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol. 72, 111-127. (Pubitemid 38519589)
43. Van Landeghem F. K., Weiss T., Oehmichen M., and, von Deimling A., (2007) Cellular localization of pituitary adenylate cyclase-activating peptide (PACAP) following traumatic brain injury in humans. Acta Neuropathol. 113, 683-693. (Pubitemid 46863904)
44. Vaudry D., Gonzalez B. J., Basille M., Fournier A., and, Vaudry H., (1999) Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc. Natl Acad. Sci. USA 96, 9415-9420. (Pubitemid 29374769)
45. Vaudry D., Gonzalez B. J., Basille M., Pamantung T. F., Fontaine M., Fournier A., and, Vaudry H., (2000) The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32. Proc. Natl Acad. Sci. USA 97, 13390-13395.
46. Vaudry D., Pamantung T. F., Basille M., Rousselle C., Fournier A., Vaudry H., Beauvillain J. C., and, Gonzalez B. J., (2002) PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur. J. Neurosci. 15, 1451-1460. (Pubitemid 35477975)
47. Vaudry D., Falluel-Morel A., Bourgault S., et al. (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol. Rev. 61, 283-357.